ImageneBio, Inc. Debt Securities, Available-for-sale
ImageneBio, Inc. (IMA) had Debt Securities, Available-for-sale of $41.48 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale $41.48M.
- 2026-03-31: Debt Securities, Available-for-sale $41.16M.
- 2025-12-31: Debt Securities, Available-for-sale $40.82M.
- 2025-09-30: Debt Securities, Available-for-sale $39.42M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $41.48M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $41.16M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $40.82M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $39.42M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $37.35M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $77.29M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | $84.99M 10-K · filed 2025-03-06 |
| 2024-09-30 | $92.84M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $101.15M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $104.50M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $55.57M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $94.60M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $93.06M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $122.92M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $97.03M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $109.78M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $144.32M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $171.49M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |